« Back
Home /
GSK-2193874 50mg

GSK-2193874 50mg

Item no.	A14201-50
Manufacturer	Adooq
CASRN	1336960-13-4
Amount	50 mg
Quantity options	1 mg 10 mg 100 mg 10mM x 1mL in DMSO 2 mg 25 mg 5 mg 50 mg
Category	Neuroscience Molecular Targets for Neuroscience Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	>98%
Smiles	C1CCN(CC1)C2CCN(CC2)CC3=C(N=C4C=C(C=CC4=C3C(=O)NC5(CC5)C6=CC=CC=C6)Br)C7=CC(=CC=C7)C(F)(F)F
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	GSK 2193874, GSK2193874
Similar products	1336960-13-4
Available
Storage Conditions	2 years at -20C
Molecular Weight	691, 62
Chemical Name	3-([1, 4-Bipiperidin]-1-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide
Description	GSK2193874 was identified as a selective, orally active TRPV4 blocker that inhibits Ca(2+) influx through recombinant TRPV4 channels and native endothelial TRPV4 currents.
Solubilty	DMSO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

A14201-50-datasheet.pdf

A14201-50-safety-datasheet.pdf